A lawsuit has been filed against Actavis Totowa on behalf of a woman who lost her husband to the defective drug Digitek in Denver. The lawsuit charges that the pharmaceutical company distributed the defective Digitek heart drug pills that contained dangerously doubled dosages of the drugs’ active ingredient digoxin. Digitek is used to treat irregular heartbeat or heart failure. The woman alleges the defective pills caused the death of her husband in August 2007. This was more than a year after FDA inspections of the manufacturing plant revealed they failed to comply with federal regulations to ensure the safety of its medications. The FDA issued a Revised Warning Letter to Actavis Totowa, LLC on February 1, 2007 finding that the inspection of the company's Little Falls, New Jersey facility that took place July 10, 2006 through August 10, 2006 revealed that drug products manufactured at that facility were adulterated under the meaning of the Federal Food, Drug and Cosmetic Act. In April 2008 the FDA recalled the double dosed drug after a number of deaths and adverse events. In August the widowed wife filed the federal lawsuit in the United States District Court in Denver, Colorado